Soligenix
SNGX
#10223
Rank
NZ$28.1 M
Marketcap
NZ$2.79
Share price
-1.23%
Change (1 day)
-48.77%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -NZ$21.42 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$16.19 Million a decrease over its 2023 earnings that were of -NZ$13.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$21.42 Million32.33%
2024 -NZ$16.19 Million22.96%
2023 -NZ$13.16 Million-45.74%
2022 -NZ$24.26 Million11.88%
2021 -NZ$21.68 Million-32.37%
2020 -NZ$32.05 Million83.18%
2019 -NZ$17.5 Million11.57%
2018 -NZ$15.69 Million19.29%
2017 -NZ$13.15 Million33%
2016 -NZ$9.89 Million-19.7%
2015 -NZ$12.31 Million5.16%
2014 -NZ$11.71 Million
2010 -NZ$13.22 Million26.12%
2009 -NZ$10.48 Million75.1%
2008 -NZ$5.99 Million-45.38%
2007 -NZ$10.96 Million-22.84%
2006 -NZ$14.2 Million66.15%
2005 -NZ$8.55 Million-16.65%
2004 -NZ$10.25 Million13.28%
2003 -NZ$9.05 Million-11.88%
2002 -NZ$10.27 Million-59.44%
2001 -NZ$25.32 Million378.18%
2000 -NZ$5.3 Million-38.53%
1999 -NZ$8.62 Million-18.43%
1998 -NZ$10.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cleveland BioLabs
CBLI
-NZ$4.77 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.28 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.75 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
NZ$20.51 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$56.07 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-NZ$72.3 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$31.43 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.06 B-14,426.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel